View source for Analysis about the effectiveness and basic safety of fibrinolytic treatments within patients along with serious STsegment top myocardial infarction during the COVID19 epidemic
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.